Phase 3 Generalized Anxiety Clinical Trials
8 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–8 of 8 trials
Recruiting
Phase 3
A Phase 3 Trial of MM120 for Generalized Anxiety Disorder (Panorama)
Generalized Anxiety Disorder
Definium Therapeutics US, Inc.250 enrolled38 locationsNCT06809595
Recruiting
Phase 3
Cannabidiol-Assisted Learning for Managing Generalized Anxiety Disorder
Anxiety DisordersGeneralized Anxiety Disorder (GAD)
Wayne State University90 enrolled1 locationNCT07123467
Recruiting
Phase 3
A Phase 3 Trial of MM120 for Generalized Anxiety Disorder (Voyage)
Generalized Anxiety Disorder
Definium Therapeutics US, Inc.200 enrolled36 locationsNCT06741228
Recruiting
Phase 3
P3b Short-term Study of CTN in Patients With ADHD and Comorbid Anxiety
AnxietySocial Anxiety DisorderADHD+1 more
Otsuka Pharmaceutical Development & Commercialization, Inc.308 enrolled47 locationsNCT06973577
Recruiting
Phase 3
Clinical Trial of Shugan Jieyu Capsule in Generalized Anxiety Disorder
Generalized Anxiety Disorder
Sichuan Jishengtang Pharmaceutical Co., Ltd.495 enrolled1 locationNCT05772104
Recruiting
Phase 3
A Study to Evaluate Efficacy and Safety of Toludesvenlafaxine Hydrochloride Sustained-release Tablets in Generalized Anxiety Disorder.
Generalized Anxiety Disorder
Luye Pharma Group Ltd.555 enrolled1 locationNCT05970510
Recruiting
Phase 3
Phase 3 Clinical Trial of Buagafuran Capsules in the Treatment of GAD
Generalized Anxiety Disorder
Beijing Union Pharmaceutical Factory Ltd504 enrolled1 locationNCT06243640
Recruiting
Phase 3
Phase Ⅲ Clinical Trial of Buagafuran Capsules in the Treatment of GAD
Generalized Anxiety Disorder
Beijing Union Pharmaceutical Factory Ltd410 enrolled1 locationNCT06243614